Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteoporosis 3Polycystic Ovary Syndrome 2Obesity 2Neoplasm Metastasis 2Lymphoma 2Leukemia 2Bone Diseases, Metabolic 2Vitamin D Deficiency 1Sexual Dysfunction, Physiological 1Psoriasis 1Pain 1Osteoarthritis 1Neoplasms 1Multiple Myeloma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypertension 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1

Interventions

Metformin 6Pioglitazone 2Exercise 2ziprasidone 1salicylsalicylic acid 1licogliflozin 1exendin (9-39) 1drospirenone and ethinyl estradiol combination 1drospirenone 1cinnulin PF 1Vitamin D 1Sugars 1Sodium Salicylate 1Resistance Training 1Olanzapine 1Leuprolide 1Flutamide 1Ethinyl Estradiol 1Estrogens 1Diet Therapy 1Continuous Positive Airway Pressure 1Cholecalciferol 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Insulin Resistance × Vitamin D × Clear all
NCT00907153 2017-12-19

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

Milton S. Hershey Medical Center

Phase 1/2 Completed
36 enrolled 44 charts

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡